LAPTM5 and cardiac hypertrophy: Indeed, deletion of LAPTM5 was found to exacerbate pressure overload-induced cardiac hypertrophy and MAPK/ERK signaling while overexpression of LAPTM5 in the heart reduced cardiac hypertrophy and MAPK/ERK activation in response to pressure overload [55].